JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+20.18%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$51.1M
AUM Growth
+$51.1M
(-35%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-54.76%
Top 10 Holdings %
Top 10 Hldgs %
78.6%
Holding
52
New
10
Increased
19
Reduced
8
Closed
12
Top Buys
| 1 |
NGD
New Gold Inc
NGD
|
$14.3M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
$2.65M |
| 3 |
Itaú Unibanco
ITUB
|
$1.32M |
| 4 |
Insmed
INSM
|
$447K |
| 5 |
Summit Therapeutics
SMMT
|
$374K |
Top Sells
| 1 |
Nu Holdings
NU
|
$15.8M |
| 2 |
StoneCo
STNE
|
$10.6M |
| 3 |
S&P Global
SPGI
|
$2.23M |
| 4 |
Incyte
INCY
|
$450K |
| 5 |
Exxon Mobil
XOM
|
$353K |
Sector Composition
| 1 | Healthcare | 42.57% |
| 2 | Materials | 30.33% |
| 3 | Technology | 23.91% |
| 4 | Financials | 2.58% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
1
New Gold Inc
NGD
$4.67B
| $14.7M | 28.6% | 5,087,997 +4,964,470 | +4,019% | +$14.3M |
|
|
2
StoneCo
STNE
$4.41B
| $12.2M | 23.83% | 1,084,358 -939,722 | -46% | -$10.6M |
|
|
3
Rhythm Pharmaceuticals
RYTM
$6.85B
| $2.95M | 5.76% | 56,378 +50,564 | +870% | +$2.65M |
|
4
Eli Lilly
LLY
$657B
| $2.12M | 4.13% | 2,389 +237 | +11% | +$210K |
|
|
ONC
5
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.1M | 4.11% | 9,375 -1,089 | -10% | -$244K |
|
|
6
Incyte
INCY
$16.5B
| $1.63M | 3.18% | 24,633 -6,801 | -22% | -$450K |
|
7
UnitedHealth
UNH
$281B
| $1.32M | 2.58% | 2,262 -139 | -6% | -$81.3K |
|
|
8
Itaú Unibanco
ITUB
$77B
| $1.32M | 2.57% | +197,897 | New | +$1.32M |
|
9
Intuitive Surgical
ISRG
$170B
| $949K | 1.85% | 1,932 +168 | +10% | +$82.5K |
|
10
Thermo Fisher Scientific
TMO
$186B
| $880K | 1.72% | 1,423 +35 | +3% | +$21.7K |
|
11
Danaher
DHR
$147B
| $688K | 1.34% | 2,474 +613 | +33% | +$170K |
|
12
Stryker
SYK
$150B
| $673K | 1.31% | 1,864 +175 | +10% | +$63.2K |
|
13
Merck
MRK
$210B
| $647K | 1.26% | 5,700 +705 | +14% | +$80.1K |
|
14
Elevance Health
ELV
$71.8B
| $638K | 1.25% | 1,227 +57 | +5% | +$29.6K |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $567K | 1.11% | 539 +210 | +64% | +$221K |
|
16
argenx
ARGX
$43.6B
| $544K | 1.06% | 1,003 +116 | +13% | +$62.9K |
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| $532K | 1.04% | 34,620 -2,120 | -6% | -$32.6K |
|
18
Agnico Eagle Mines
AEM
$72.4B
| $523K | 1.02% | 6,497 | – | – |
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $451K | 0.88% | 969 -77 | -7% | -$35.8K |
|
20
AstraZeneca
AZN
$248B
| $449K | 0.88% | 5,768 +1,137 | +25% | +$88.6K |
|
|
21
Insmed
INSM
$28.8B
| $447K | 0.87% | +6,123 | New | +$447K |
|
22
Amgen
AMGN
$155B
| $439K | 0.86% | 1,362 +314 | +30% | +$101K |
|
23
Alnylam Pharmaceuticals
ALNY
$58.5B
| $426K | 0.83% | 1,548 +315 | +26% | +$86.6K |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $423K | 0.83% | 1,993 +660 | +50% | +$140K |
|
|
25
Summit Therapeutics
SMMT
$17.6B
| $374K | 0.73% | +17,080 | New | +$374K |
|